Clik here to view.
Using Bioprinting Technology, San Diego’s Organovo Makes 3D Tissue
Bruce V. Bigelow Organovo, a San Diego regenerative medicine company developing bio-printing technology, says it has used its proprietary NovaGen bioprinter to produce 3D samples of human liver cells...
View ArticleClik here to view.
SMC Bio Looks to Heal Bones With Carbohydrates, Not Stem Cells
Luke Timmerman The secret to regenerative medicine doesn’t really lie in a lab dish with stem cells, or some engineered protein that stimulates tissue growth, at least to the folks at one Bay Area...
View ArticleClik here to view.
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More
Bruce V. Bigelow A number of San Diego life sciences companies appeared to be taking advantage of the strengthening biotech market on Wall Street by raising capital or repositioning themselves—or...
View ArticleClik here to view.
San Diego Life Sciences Roundup: Vical, Fate, Arcturus, and More
Bruce V. Bigelow Amid favorable market conditions for the life sciences industry, another San Diego biotech has filed to go public. We have details, along with other local developments over the past...
View ArticleClik here to view.
Histogen Wins Legal Ruling in Saga of Entrepreneurial Perseverance
Bruce V. Bigelow [Corrected 8/27/13, 5:50 pm. See below.] Back in 2011, when a federal judge in San Diego issued a summary judgment for San Diego-based Histogen in a patent dispute, CEO Gail Naughton...
View ArticleClik here to view.
An Insider’s Antidote for Dangerous Stem Cell Hype
Bernadette Tansey UC Davis professor Paul Knoepfler’s new book about stem cells may never break into the New York Times best-seller ranks, but he still might make some publishing history. Knoepfler...
View ArticleClik here to view.
San Diego’s Celladon Sets Price Range for IPO Shares
Bruce V. Bigelow Another San Diego life sciences company is taxiing toward an IPO takeoff. Celladon, a biotechnology company targeting heart disease, disclosed plans to offer 5 million shares of its...
View ArticleClik here to view.
San Diego Life Sciences Roundup: Santarus, Cytori, IPOs, and More
Bruce V. Bigelow This was a big week for life sciences news in San Diego. A very big week. So without further ado: —Salix Pharmaceuticals (NASDAQ: SLXP) of Raleigh, NC, said it’s buying San...
View ArticleClik here to view.
With Dermagraft Sale, Shire Jettisons Business Acquired 3 Years Ago
Bruce V. Bigelow Shire (NASDAQ: SHPG) engendered some high expectations after the Irish biopharmaceutical giant acquired San Diego’s Advanced BioHealing in 2011 for $750 million. Over the next year or...
View ArticleClik here to view.
$40M Establishes New Center for Stem Cell Genomics in Bay Area, SD
Bruce V. Bigelow The California Institute for Regenerative Medicine today awarded $40 million to create a new Center of Excellence in Stem Cell Genomics, to be led by Stanford University molecular...
View ArticleClik here to view.
Ex-Harvard Bio Prez Leads Spin-Off’s Plan to Make Engineered Organs
Ben Fidler David Green had led Holliston, MA-based Harvard Bioscience (NASDAQ: HBIO) for almost two decades when he was faced with a big career choice. The company was about to spin off a new firm...
View ArticleClik here to view.
BioHouston Life Science Forum Spotlights Texas Biotech Innovation
Angela Shah Life sciences leaders gathered last week in a Rice University auditorium for BioHouston’s Life Science Forum where they heard keynotes and panel discussions on Texas biotech’s challenges...
View ArticleClik here to view.
With Gene Therapy, VentriNova Aims to Mend Broken Hearts
Ben Fidler When a baby is born, a pretty important type of gene shuts down. The gene that carries the instructions for making the heart does its job when the baby is in the womb, and it turns off when...
View ArticleClik here to view.
In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products
Sarah Schmid More than a year after the failure of its lead program forced a major overhaul, Aastrom Biosciences (NASDAQ:ASTM) announced Monday it had acquired pharmaceutical giant Sanofi’s cell...
View ArticleClik here to view.
West Coast Biotech Roundup: NanoString, Sequenom/Agena, CIRM, & More
Alex Lash In the life sciences, much of the attention was focused in the past week on the American Society of Clinical Oncology conference in Chicago. We’ll have a separate roundup of that news,...
View ArticleClik here to view.
Wake Forest Institute Advancing Bioprinter Tech for Wound Care
Bernadette Tansey In the not too distant future, one of the most important pieces of equipment for treating injured soldiers at a combat hospital could be a printer. Doctors may someday wheel a...
View ArticleClik here to view.
Doctors Close to Implanting First Stem-Cell Therapy for Diabetes
Bruce V. Bigelow Researchers from San Diego-based ViaCyte and UC San Diego provided new details about the first-ever human clinical trial of a stem cell-derived therapy for patients with type 1...
View ArticleClik here to view.
Cellular Dynamics Gets Into Regenerative Medicine With Eye Cell Deal
Jeff Engel Cellular Dynamics International, the Madison, WI-based provider of human cells, took its first big step into regenerative medicine today with the announcement of a $1.2 million contract...
View ArticleClik here to view.
From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step
Jeff Engel Cellular Dynamics International CEO Bob Palay envisions a world where the eyes of a person going blind from macular degeneration can be healed by implanting healthy retinal cells that were...
View ArticleClik here to view.
Stratatech Eyes Phase 3 Trial Of Regenerative Tissue For Burn Wounds
Jeff Engel Stratatech moved closer this week to commercializing its skin-like tissue intended to coax patients with burn wounds to naturally regrow skin. The Madison, WI-based company on Tuesday...
View Article